These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6375670)

  • 1. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala).
    Bessler WG; Cox M; Wiesmüller KH; Jung G
    Biochem Biophys Res Commun; 1984 May; 121(1):55-61. PubMed ID: 6375670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins.
    Biesert L; Scheuer W; Bessler WG
    Eur J Biochem; 1987 Feb; 162(3):651-7. PubMed ID: 3549292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
    Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
    J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein.
    Bessler WG; Johnson RB; Wiesmüller K; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens.
    Bessler WG; Henning U
    Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):387-98. PubMed ID: 382663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo.
    Johnson RB; Köhl S; Wiesmüller K; Jung G; Bessler WG
    Immunobiology; 1983 Jul; 165(1):27-35. PubMed ID: 6350164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenicity of a lipid-deficient lipoprotein from a mutant Escherichia coli strain.
    Bessler WG; Simon E; Rotering H
    Infect Immun; 1980 Jun; 28(3):818-23. PubMed ID: 6995322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of N-palmitoyl-cysteine and N-palmitoyl-glutamic acid alpha-methyl ester.
    Cybulla J; Brückner H; Jung G; Wipperfürth T; Bessler WG
    Biochem Biophys Res Commun; 1980 Feb; 92(4):1389-96. PubMed ID: 6989366
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of biologic activities of synthetic lipopentapeptide analogs of bacterial lipoprotein in mice.
    Shimizu T; Ohtsuka Y; Yanagihara Y; Kurimura M; Takemoto M; Achiwa K
    Mol Biother; 1991 Mar; 3(1):46-50. PubMed ID: 2069759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.
    Melchers F; Braun V; Galanos C
    J Exp Med; 1975 Aug; 142(2):473-82. PubMed ID: 1095681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.
    Lex A; Wiesmüller KH; Jung G; Bessler WG
    J Immunol; 1986 Oct; 137(8):2676-81. PubMed ID: 3531339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal activation of B-lymphocytes in vivo by Salmonella typhimurium lipoprotein.
    Johnson RB; Köhl S; Bessler WG
    Infect Immun; 1983 Mar; 39(3):1481-4. PubMed ID: 6341238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a synthetic analogue of mitogenic bacterial lipoprotein to murine major histocompatibility complex (MHC) gene products.
    Scheuer WV; Biesert L; Bessler WG
    Biol Chem Hoppe Seyler; 1986 Oct; 367(10):1085-94. PubMed ID: 3491614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein.
    Brade L; Bessler WG; Brade H
    Infect Immun; 1988 May; 56(5):1382-4. PubMed ID: 3281910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of the Escherichia coli lipoprotein: detection of novel lymphocyte activating peptide segments of the molecule and their conformational characterization.
    Loleit M; Deres K; Wiesmüller KH; Jung G; Eckert M; Bessler WG
    Biol Chem Hoppe Seyler; 1994 Jun; 375(6):407-12. PubMed ID: 7980873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli.
    Bessler W; Resch K; Hancock E; Hantke K
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):11-22. PubMed ID: 325934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the aggregational state on the mitogenicity of lipoprotein from the outer membrane of Escherichia coli.
    Haas IG; Simon E; Bessler WG
    Immunobiology; 1980 Jan; 156(4-5):418-28. PubMed ID: 6989749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.
    Prass W; Ringsdorf H; Bessler W; Wiesmüller KH; Jung G
    Biochim Biophys Acta; 1987 Jun; 900(1):116-28. PubMed ID: 3297144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS.
    Skidmore BJ; Morrison DC; Chiller JM; Weigle WO
    J Exp Med; 1975 Dec; 142(6):1488-1508. PubMed ID: 1104747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenic activity and the induction of tumor necrosis factor by lipopeptide analogs of the N-terminal part of lipoprotein in the outer membrane of Escherichia coli.
    Shimizu T; Iwamoto Y; Yanagihara Y; Kurimura M; Achiwa K
    Biol Pharm Bull; 1994 Jul; 17(7):980-2. PubMed ID: 8000390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.